Fairness opinions › Acquirers
Covidien: healthcare acquisitions with fairness opinions
2 public-company targets, 2010-2010, $2.8B combined enterprise value. The multiples Covidien paid and the banker analyses behind each target board's recommendation.
Deals
2
Median EV / EBITDA paid
24.2x
Median EV / revenue paid
4.58x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2010-06-14 | Somanetics | Covidien | Medical Devices and Supplies | $250M | 20.5x | 4.39x | 11.8%–13.8% | Leerink Partners |
| 2010-06-01 | ev3 | Covidien | Medical Devices and Supplies | $2.5B | 27.9x | 4.78x | 10.5%–12.0% | J.P. Morgan, Piper Sandler |